Tech Company Financing Transactions
Sonexa Therapeutics Funding Round
Sonexa Therapeutics, based in San Diego, raised $1.2 million from private investors.
Transaction Overview
Company Name
Announced On
4/4/2012
Transaction Type
Debt
Amount
$1,224,992
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
The company is developing treatments for Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eckard Weber
Chief Financial Officer
Lynne Rollins
Chief Medical Officer
Martin Koller
VP - R & D
Tilman Oltersdorf
VP - Regulatory Affairs
Barbara Finn
Browse more venture capital transactions:
Prev: 4/4/2012: Krossover venture capital transaction
Next: 4/4/2012: Nitro venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs